 Press Release Distribution |
 |
- PR Home
- Latest News
- Feeds
- Alerts
- Submit Free Press Release
- Journalist Account
- PRNewswire Distribution
Filter News Show All ResultsNews By Country
News By Tag Drug Development  Related Tags Biotech
Biotechnology Cancer Clinical Research Clinical Research Associates Clinical Research Jobs Clinical Trials Cra Jobs Cro Drug Drug Discovery Drugs Event Pharma Pharma Development Pharmaceutical Pharmaceuticals Pharmacokinetics Regulatory Affairs San Francisco
| drug development Latest News+ XML/RSSBy Calvert Holdings, Inc. Scott Township, PA – June 10, 2013 – Calvert Labs and EyeCRO, two leading providers in early-stage ocular drug research and development, announced today that they have entered into a strategic partnership to expedite preclinical drug development... By Rosa & Co PhysioPD™ modeling collaboration in psoriasis to be presented May 20-22, 2013. By Rosa & Co Dr. Bottino will present the Webinar “Multi-scale modeling to optimize the antitumor effect of antibody-dependent cell-mediated cytotoxicity (ADCC) enhanced therapies” on June 19, 2013. By Veristat Collaboration offers clients more streamlined and efficient approach to trial planning By Mary Ann Liebert, Inc., publishers Tumor repressor genes, which inhibit tumor formation, can be "turned off" due to undesirable molecular changes affecting the chromosomes on which the genes reside. By Cambridge Healthtech Institute Mar. 20, 2013 - Needham, MA - Part of Cambridge Healthtech Institute’s Bio-IT World Expo, attendees will gain first-hand insight from three plenary keynote presentations, aligned with the event theme of new trends in data generation, knowledge... By Cures Within Reach Understanding Drug Development will be the second webcast in the RARE Webinar Series providing relevant information to patients and caregivers battling rare diseases, which are defined as diseases that affect fewer than 200,000 people in the US and... By cardiabase CardiaBase, a global provider of centralized diagnostic services to clinical trials, is pleased to announce that Dr. Pierre Maison-Blanche joined the company as Chief Medical Officer. By Cambridge Healthtech Institute Plenary Keynote Panels on "Personalized Oncology: Fulfilling the Promise for Today’s Patients" and "Emerging Technologies & Industry Perspectives" to be Delivered Next Month in San Francisco By SMi Group Imaging in Cancer Drug Development taking place in London, March 2013, focuses on current developments surrounding oncology imaging and overcoming chemical challenges in radiotracer development. By Cambridge Healthtech Institute Gain access to solutions and connections for Diagnostics, Informatics, Clinical, Cancer, Therapeutics, Sequencing, Genomics and Medicine and more at Cambridge Healthtech Institute's 20th Annual Molecular Medicine Tri-Conference By Cambridge Healthtech Institute Cambridge Healthtech Institute's Patient-Derived Cancer Tissue Xenograft Models Short Course is being held at the Molecular Med TRI-CON 2013 on February 12th at the Moscone North Convention Center in San Francisco. By Biotech Support Group LLC Cholesterol removal from serum samples using Cleanascite™ for immunogenicity and safety endpoint analysis of pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine. By Cambridge Healthtech Institute International Experts in Computational Drug Design, Genome Interpretation, and an All-Star CIO Panel Headline 2013 Bio-IT Conference in Boston By SMi Group EU regulations on paediatric drug development are becoming more and more complicated and pharmaceutical companies have to prepare more robust and detailed paediatric investigation plans to ensure the success of their clinical trials By Arrowhead Publishers and Conferences The 2nd Annual Drug Repositioning and Indications Discovery Conference is being held on October 23-24, 2012 in San Francisco, CA. This conference will feature a variety of speakers from academia, industry, non-profits and government. By Cambridge Healthtech Institute Aptiv Solutions, Berry Consultants and Tessella announce a one day forum to address the challenges in adopting adaptive trials in the drug, medical device and clinical research industry and assess the potential for transforming drug development. By Biotech Support Group Cleanascite™ from Biotech Support Group cleans up samples and it extends the life of membrane and chromatographic columns for large scale monoclonal antibody purification By Biotech Support Group UPCK™ Urine Protein Enrichment/Concentration Kit features a urinary protein enrichment optimized protocol for sample preparation and downstream analysis of urine samples By OneWorld Health/PATH Dr. Ponni Subbiah will join OneWorld Health on August 1st, 2012 as its first global program leader. All Press ReleasesBy Calvert Holdings, Inc. Scott Township, PA – June 10, 2013 – Calvert Labs and EyeCRO, two leading providers in early-stage ocular drug research and development, announced today that they have entered into a strategic partnership to expedite preclinical drug development... By Rosa & Co PhysioPD™ modeling collaboration in psoriasis to be presented May 20-22, 2013. By Rosa & Co Dr. Bottino will present the Webinar “Multi-scale modeling to optimize the antitumor effect of antibody-dependent cell-mediated cytotoxicity (ADCC) enhanced therapies” on June 19, 2013. By Mary Ann Liebert, Inc., publishers New Rochelle, May 16, 2013–Lethal and rescuer genes are defined as genes that when inactivated result in cell death or enhanced cell growth, respectively. By Veristat Collaboration offers clients more streamlined and efficient approach to trial planning By Mary Ann Liebert, Inc., publishers Tumor repressor genes, which inhibit tumor formation, can be "turned off" due to undesirable molecular changes affecting the chromosomes on which the genes reside. By SMi Group Ltd Adaptive Designs in Clinical Trials to take place in London, UK, 8th & 9th April... By Cambridge Healthtech Institute Mar. 20, 2013 - Needham, MA - Part of Cambridge Healthtech Institute’s Bio-IT World Expo, attendees will gain first-hand insight from three plenary keynote presentations, aligned with the event theme of new trends in data generation, knowledge... By Cures Within Reach Understanding Drug Development will be the second webcast in the RARE Webinar Series providing relevant information to patients and caregivers battling rare diseases, which are defined as diseases that affect fewer than 200,000 people in the US and... By Calvert Holdings, Inc. Scott Township, PA – Calvert Laboratories and Particle Sciences, two leading companies in their respective fields of preclinical toxicology and drug product formulation, announced today that they have joined forces to offer a streamlined solution to... By cardiabase CardiaBase, a global provider of centralized diagnostic services to clinical trials, is pleased to announce that Dr. Pierre Maison-Blanche joined the company as Chief Medical Officer. By Cambridge Healthtech Institute Plenary Keynote Panels on "Personalized Oncology: Fulfilling the Promise for Today’s Patients" and "Emerging Technologies & Industry Perspectives" to be Delivered Next Month in San Francisco By SMi Group Imaging in Cancer Drug Development taking place in London, March 2013, focuses on current developments surrounding oncology imaging and overcoming chemical challenges in radiotracer development. By Cambridge Healthtech Institute Gain access to solutions and connections for Diagnostics, Informatics, Clinical, Cancer, Therapeutics, Sequencing, Genomics and Medicine and more at Cambridge Healthtech Institute's 20th Annual Molecular Medicine Tri-Conference By Cambridge Healthtech Institute Cambridge Healthtech Institute's Patient-Derived Cancer Tissue Xenograft Models Short Course is being held at the Molecular Med TRI-CON 2013 on February 12th at the Moscone North Convention Center in San Francisco. By Adaptive Clinical Systems ACRIM, a leading imaging Contract Research Organization (iCRO), has selected Adaptive Clinical Systems’ Cloud-based e-Clinical solution for its EDC needs. By Biotech Support Group LLC Cholesterol removal from serum samples using Cleanascite™ for immunogenicity and safety endpoint analysis of pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine. By Cambridge Healthtech Institute International Experts in Computational Drug Design, Genome Interpretation, and an All-Star CIO Panel Headline 2013 Bio-IT Conference in Boston By SMi Group EU regulations on paediatric drug development are becoming more and more complicated and pharmaceutical companies have to prepare more robust and detailed paediatric investigation plans to ensure the success of their clinical trials By PATH OneWorld Health PATH's Drug Development program has developed a new medication to treat diarrhea. This new drug treats the diarrheal process to shorten its duration. By Rosa & Co Dr. Lo will present the Webinar “Integration of in vitro data into a viral kinetics model to investigate rapid development of Hepatitis C resistance to therapy” on November 14, 2012. By Rosa & Co Dr. Gordi, will discuss choice of models and their Impact in the Drug Development Process at 4th World PK/PD Summit on November 28, 2012 in Frankfort, Germany By Cambridge Healthtech Institute Find Strategies to Maximize microRNA as a Target and Tool for Therapeutic Development By Arrowhead Publishers and Conferences The 2nd Annual Drug Repositioning and Indications Discovery Conference is being held on October 23-24, 2012 in San Francisco, CA. This conference will feature a variety of speakers from academia, industry, non-profits and government. By kdm communications Deal marks Avacta’s entry to the third largest Asia-Pacific biotech market By World Trade Group We’re pleased to announce that Andreas Schneider, Vice President Life Science Alliances, Roche, will be speaking at the Early Drug Development Summit, 3rd - 4th December 2012 at the Hotel Palace Berlin, Germany. By Cambridge Healthtech Institute Aptiv Solutions, Berry Consultants and Tessella announce a one day forum to address the challenges in adopting adaptive trials in the drug, medical device and clinical research industry and assess the potential for transforming drug development. By Rosa & Co Dr. Rowland, will present “Drug development and physiologically based pharmacokinetics” Webinar September 19, 2012 By Mary Ann Liebert, Inc., publishers The use of RNA in nanotechnology applications is highly promising for many applications, including the development of new therapeutic compounds. By ICRC-Weyer GmbH Innovation in drug development requires flexibility in the clinical trial design, not merely standardisation, according to Prof Dr Geerd Weyer, Managing Director at ICRC-Weyer clinical contract research organisation. By Biotech Support Group Cleanascite™ from Biotech Support Group cleans up samples and it extends the life of membrane and chromatographic columns for large scale monoclonal antibody purification By Biotech Support Group UPCK™ Urine Protein Enrichment/Concentration Kit features a urinary protein enrichment optimized protocol for sample preparation and downstream analysis of urine samples By Biotech Support Group NuGel™ Glycoprotein Enrichment PBA product is ideal for mining glycoproteins and represents a new paradigm for biomarker discovery from glycoproteins. By OneWorld Health/PATH Dr. Ponni Subbiah will join OneWorld Health on August 1st, 2012 as its first global program leader. By Biotech Support Group Hemoglobin Depletion Plus Protein Enrichment From Dried Blood Spot (Blood Card) Technology By Biotech Support Group Signup to attend protein enrichment webinar series to explore proteomics and genomic sample preparation products and research featuring albumin depletion, urine protein enrichment, glycoproteins enrichment. By CRC Press Covers the regulatory requirements, scientific and practical issues, and statistical methodology for designing and evaluating bridging studies and multiregional clinical trials, with the goal of inspiring new research activities in the field. By Biotech Support Group Cleanascite™ for lipid removal and identification of biomarkers for environmental contamination from fish bile samples containing metalloproteinases By Rosa & Co Dr. Siler, will present “The DILIsym™ model and its application to hepatotoxicity testing in drug development” Webinar June 19, 2012 By Rosa & Co Dr. Gordi, will present “Mechanistic PK/PD Modeling in Pediatrics” Webinar May 22, 2012. By Alex Durand-Salmon Banook, a leading clinical trial service provider, is pleased to announce the launch of Banook Central Imaging (www.banook-ci.com), a global service organization providing medical imaging services for clinical research area. By Rosa & Co Dr. Schoeberl will present “Using Mathematical Models To Set Design Criteria For Antibody-Based Therapies” April 17, 2012. By Cambridge Healthtech Institute Those that missed last month's event can get a CD with 350 speaker presentations from 16 conferences within 4 scientific channels: diagnostics, drug discovery & development, informatics and cancer. TriConference.com Rosa Announces Publication of its PhysioPD Model Qualification Method and Series of Educational Even By Rosa & Co Series of Seminars and Workshops to be held in 2012 across the US and in Europe By Impuls Public Relations OG Vela Laboratories and Anagnostics enter strategic partnership to offer hybcell technology to biotech and pharma customers under GMP conditions. By Cambridge Healthtech Institute Join us for a roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Discussion moderated by: Norman J. Maitland, Ph.D., Chief Scientific Officer, Procure Therapeutics Ltd. By Biopontis Alliance Collaboration will combine Rosa’s PhysioPD™ modeling & simulation capabilities with Biopontis’ innovative asset sourcing and financial structure to improve early drug development productivity By Cambridge Healthtech Institute A roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Moderated by: Ho Sung Cho, Ph.D., Chief Technical Officer, Ambrx. By Cambridge Healthtech Institute A roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Moderatored by: Gary Starling, Ph.D., Director, GPRD Discovery, Oncology Biologics, Abbott Biotherapeutics Corp. By Cambridge Healthtech Institute CHI’s Cancer Biologics conference is a 3-day event based on in-depth research with experts in the field. | ||||||||||||||||||||||
Like PRLog?
8.4K1.9K2.6K